Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans. Brogden NK, Banks SL, Crofford LJ, Stinchcomb AL (2013) Pharm Res 30: 1947-55 Comparative study of the skin penetration of protein transduction domains and a conjugated peptide. Lopes LB, Brophy CM, Furnish E, Flynn CR, Sparks O, Komalavilas P, Joshi L, Panitch A, Bentley MV (2005) Pharm Res 22: 750-7 Enhanced skin penetration of P20 phosphopeptide using protein transduction domains. Lopes LB, Furnish E, Komalavilas P, Seal BL, Panitch A, Bentley MV, Brophy CM (2008) Eur J Pharm Biopharm 68: 441-5 Development of in vivo impedance spectroscopy techniques for measurement of micropore formation following microneedle insertion. Brogden NK, Ghosh P, Hardi L, Crofford LJ, Stinchcomb AL (2013) J Pharm Sci 102: 1948-1956 Maximizing the in vivo efficiency of gene transfer by means of nonviral polymeric gene delivery vehicles. Prokop A, Kozlov E, Moore W, Davidson JM (2002) J Pharm Sci 91: 67-76 An orthogonal methods assessment of topical drug concentrations in skin and the impact for risk assessment in the viable epidermis. Hollingshead BD, Tomlinson L, Finley J, Doshna C, Ritenour C, Barricklow J, Oppenheimer SR, O'Neil SP, Moore JL, Patterson NH, Nicholson SP, Norris JL, Caprioli RM, Beaumont K, King-Ahmad AJ, Vispute S, Cook JC, Radi Z, Schuler M (2021) Regul Toxicol Pharmacol 123: 104934 Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of pelargonic acid (nonanoic acid) and nonanoate esters. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Klaassen CD, Hill R, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2011) Int J Toxicol 30: 228S-69S
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.